Your browser doesn't support javascript.
loading
The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Giles, Francis J; Bellamy, William T; Estrov, Zeev; O'Brien, Susan M; Verstovsek, Srdan; Ravandi, Farhad; Beran, Miloslav; Bycott, Paul; Pithavala, Yazdi; Steinfeldt, Heidi; Reich, Steven D; List, Alan F; Yee, Karen W L.
Affiliation
  • Giles FJ; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX 77030, USA. frankgiles@aol.com
Leuk Res ; 30(7): 801-11, 2006 Jul.
Article in En | MEDLINE | ID: mdl-16332390
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid / Angiogenesis Inhibitors / Imidazoles / Indazoles / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged80 Language: En Journal: Leuk Res Year: 2006 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid / Angiogenesis Inhibitors / Imidazoles / Indazoles / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged80 Language: En Journal: Leuk Res Year: 2006 Type: Article Affiliation country: United States